Accelerating 21st Century Cures

This is a golden age for biomedical research, with novel technologies and groundbreaking science revealing new pathways to diagnose, treat, prevent, or cure disease. Yet too many patients still lack lifesaving therapies. Last year, the US House Committee on Energy and Commerce launched the bipartisan 21st Century Cures initiative to consider opportunities to transform biopharmaceutical research and development. Now under review in Congress, the 21st Century Cures Act, proposes new ways to streamline clinical trials, incorporate patient perspectives into decision making, and speed the science of cures to the bedside. Are fundamental changes needed in how we invest in and oversee research, product development and review? Where along the arc of discovery, testing, approval, and marketing can we accelerate the pace of biomedical advances?

Festival: Spotlight Health 2015

Watch and Listen: Treatment

Illness and death are universal challenges, but not something we anticipate in our 30s. Kate Bowler and Lucy Kalanithi... See more
College presents opportunities for students to test their wings, explore new relationships, pursue their personal best... See more
Over the past 20 years, almost 200,000 children under age 18 have been shot. Nearly as many attend schools where a... See more
Larry Smarr believes in being the CEO of his own body, and for years, he has been measuring inputs (food and drink) and... See more
Whether the headlines describe a “cancer moonshot” or a “war on cancer,” they capture a yearning and determination to... See more
Although infectious disease outbreaks, from influenza to Ebola, surface with alarming frequency, more than 80% of the... See more